The ARF Tumor Suppressor
The ARF Tumor Suppressor
批准号:
8403760
负责人:
Maureen E. Murphy
金额:
$32.54万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-01-01 至 2014-12-31
关键词:
1-Phosphatidylinositol 3-Kinase3-methyladenineANXA2 geneAbbreviationsAddressAmino AcidsAntineoplastic AgentsAutophagocytosisBindingBinding ProteinsBiochemistryBreast CarcinomaBuffersBurkitt LymphomaCDKN2A geneCalciumCatabolic ProcessCell LineCell SurvivalCellsChemicalsChloroquineDataDevelopmentDigestionDisaccharidesE2F1 geneFoundationsGenesGeneticGlucoseGoalsGrowthHumanLipidsLymphomaLysosomesMDM2 geneMalariaMalignant NeoplasmsMass Spectrum AnalysisMediatingMediator of activation proteinMembraneMetabolic stressMitochondriaMitochondrial ProteinsMusMutateMutationNutrientOncogenicOrganellesOvarian CarcinomaPathway interactionsPharmaceutical PreparationsPhosphatidylinositide 3-Kinase InhibitorPhospholipidsPhosphotransferasesPlayProcessProteinsResearchRheumatoid ArthritisRoleSignal TransductionSodium ChlorideSolutionsStarvationStressTerminologyTestingTrehaloseTumor Suppressor GenesTumor Suppressor ProteinsUp-Regulationc-myc Genescancer cellcancer therapycombatdeprivationgene repressionhuman FRAP1 proteinin vivoinhibitor/antagonistmutantneoplastic cellnovelnucleophosminoverexpressionp19ARFpublic health relevanceresponsesarcomasmall moleculetumortumorigenesisubiquitin ligase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The ARF tumor suppressor protein is encoded by the Ink4a/ARF gene, which is the second most frequently mutated genetic locus in human cancer. To date the majority of research on ARF has focused on its tumor suppressor functions. This proposal focuses instead on a novel survival function for ARF that we have recently uncovered, and that exists for a subset of tumors with mutant/null p53. We show that ARF plays an integral role in starvation-induced autophagy. Autophagy is a self-catabolic process that promotes the survival of cells exposed to nutrient deprivation. Because tumor cells exist under uniquely metabolically-stressed conditions, many rely heavily on this pathway in order to subsist. Consistent with this fact, autophagy inhibitors have shown promise as anti-cancer agents. We show that ARF protein is markedly up-regulated in response to nutrient deprivation. We show that silencing ARF impedes autophagy and decreases the survival of nutrient-deprived cells. Finally, we show that silencing ARF in lymphomas impairs autophagy and survival, and actually impedes the development of these tumors. The central hypothesis of this proposal is that ARF-mediated autophagy is utilized by a subset of tumors with mutant p53 to allow them to survive episodes of metabolic stress. We contend that the requirement for the survival function of autophagy is an 'Achilles heel' for tumors. We need to better understand this pathway in order to exploit it for cancer therapy. In proposed research we will elucidate the mechanism(s) whereby ARF induces autophagy. We will determine how nutrient deprivation leads to increased ARF protein levels. We have found that ARF expression is beneficial for some tumors (lymphoma) but not others (sarcoma); we will define the subset of tumors that are benefited by ARF-mediated autophagy. We will determine whether critical mediators of autophagy, such as ARF and Beclin1, dictate tumor response to small molecules that modulate this process, such as chloroquine (inhibits autophagy), and trehalose (induces autophagy). Finally we will elucidate the mechanism of transcriptional repression of the ARF locus by p53, as this leads to ARF up-regulation in p53-mutant tumors. The combined data will serve as a necessary foundation for exploiting the pathway of autophagy for cancer therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Functional Analysis of p53 Polymorphic Variants - Diversity Supplement
-
批准号:10818904
-
项目类别:
-
资助金额:$4.37万
-
财政年份:2023
-
负责人:Maureen E. Murphy
-
依托单位:
The genetics of tumor suppression by p53
-
批准号:10636305
-
项目类别:
-
资助金额:$42.22万
-
财政年份:2023
-
负责人:Maureen E. Murphy
-
依托单位:
Purchase of a SARRP 200 Platform for Irradiation
-
批准号:10430904
-
项目类别:
-
资助金额:$60.0万
-
财政年份:2022
-
负责人:Maureen E. Murphy
-
依托单位:
The impact of coding region variants on mutant p53 biology
-
批准号:10304135
-
项目类别:
-
资助金额:$43.6万
-
财政年份:2019
-
负责人:Maureen E. Murphy
-
依托单位:
The impact of coding region variants on mutant p53 biology
-
批准号:10523512
-
项目类别:
-
资助金额:$43.6万
-
财政年份:2019
-
负责人:Maureen E. Murphy
-
依托单位:
The impact of coding region variants on mutant p53 biology
-
批准号:9914543
-
项目类别:
-
资助金额:$48.41万
-
财政年份:2019
-
负责人:Maureen E. Murphy
-
依托单位:
The impact of coding region variants on mutant p53 biology
-
批准号:10063505
-
项目类别:
-
资助金额:$44.48万
-
财政年份:2019
-
负责人:Maureen E. Murphy
-
依托单位:
p53 Variants in Cancer Risk and Therapy
-
批准号:9188088
-
项目类别:
-
资助金额:$42.14万
-
财政年份:2015
-
负责人:Maureen E. Murphy
-
依托单位:
p53 Variants in Cancer Risk and Therapy
-
批准号:9007017
-
项目类别:
-
资助金额:$46.64万
-
财政年份:2015
-
负责人:Maureen E. Murphy
-
依托单位:
p53 Variants in Cancer Risk and Therapy
-
批准号:9377535
-
项目类别:
-
资助金额:$42.83万
-
财政年份:2015
-
负责人:Maureen E. Murphy
-
依托单位:
Tuberculosis Surveillance, Prevention and Control, and Laboratory Upgrade
-
批准号:8009855
-
项目类别:
-
资助金额:$117.49万
-
财政年份:2010
-
负责人:Maureen E. Murphy
-
依托单位:
Tuberculosis Surveillance, Prevention and Control, and Laboratory Upgrade
-
批准号:7927847
-
项目类别:
-
资助金额:$121.11万
-
财政年份:2010
-
负责人:Maureen E. Murphy
-
依托单位:
HSP70 and melanoma
-
批准号:8976556
-
项目类别:
-
资助金额:$46.2万
-
财政年份:2010
-
负责人:Maureen E. Murphy
-
依托单位:
HSP70 and melanoma
-
批准号:9096787
-
项目类别:
-
资助金额:$43.95万
-
财政年份:2010
-
负责人:Maureen E. Murphy
-
依托单位:
Tuberculosis Surveillance, Prevention and Control, and Laboratory Upgrade
-
批准号:8203599
-
项目类别:
-
资助金额:$115.89万
-
财政年份:2010
-
负责人:Maureen E. Murphy
-
依托单位:
The ARF Tumor Suppressor
-
批准号:8011341
-
项目类别:
-
资助金额:$35.12万
-
财政年份:2010
-
负责人:Maureen E. Murphy
-
依托单位:
The ARF Tumor Suppressor
-
批准号:7779140
-
项目类别:
-
资助金额:$36.21万
-
财政年份:2010
-
负责人:Maureen E. Murphy
-
依托单位:
The ARF Tumor Suppressor
-
批准号:8205015
-
项目类别:
-
资助金额:$34.08万
-
财政年份:2010
-
负责人:Maureen E. Murphy
-
依托单位:
Targeting HSP70 for MelanomaTherapy
-
批准号:10471235
-
项目类别:
-
资助金额:$45.55万
-
财政年份:2008
-
负责人:Maureen E. Murphy
-
依托单位:
Targeting HSP70 for MelanomaTherapy
-
批准号:10239040
-
项目类别:
-
资助金额:$46.58万
-
财政年份:2008
-
负责人:Maureen E. Murphy
-
依托单位:
国内基金
海外基金
神经元缺血性"程序性坏死"调控机制及3-methyladenine保护机制研究
-
批准号:81100877
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:汪敬业
-
依托单位: